Health Care

2724 posts
Eli Lilly widens its lead over Novo Nordisk as demand for weight-loss drugs drives higher revenue

Weight-loss drug boom widens Lilly’s lead over Novo

Eli Lilly’s revenue surged 48 per cent as Mounjaro and Zepbound widened its commercial lead over rival Novo Nordisk.

The 5-Minute Investor Podcast, Ep. 72: The next AI gold rush is copper

Check out ep. 72 of The 5-Minute Investor Podcast, with analysis on copper stocks Freeport-McMoRan and Capstone Copper.

EU authorizes new COVID vaccine from Pfizer and BioNTech

The EU grants marketing authorization to Pfizer and BioNTech's COVID-19 vaccine targeting the new XFG variant.

PharmaTher evaluating 3D printing for personalized peptide medicines

PharmaTher is out to evaluate its GMP-ready 3D printing platform for producing personalized peptide medicines with customized doses.

Why biotech is outpacing the AI slump: 3 stocks to watch

The biotech sector is outperforming the broader market, shining a light on stocks best-positioned to address unmet patient needs.

The 5-Minute Investor Podcast, Ep. 71: Weight-loss drug stocks

Listen to ep. 71 of The 5-Minute Investor Podcast, with analysis on weight-loss drug stocks Structure Therapeutics and Viking Therapeutics.

A small-cap contender looking to challenge the weight-loss drug giants

Structure Therapeutics (NASDAQ:GPCR) is developing an oral weight-loss pill that could offer an alternative to popular injectable treatments.

Buzz on the Bullboards: Pulse check on healthcare stocks

Canadian companies have made headlines from breakthrough detection tech to financing initiatives to mission-critical software enhancements.

The economics of obesity drugs: Reimbursement, pricing power, and the next healthcare cost debate

Breakthrough obesity drugs are highly effective but priced at levels that create significant affordability challenges at scale.

Gary Payton II joins multi-bagger drug technology company

Vector Science & Therapeutics (TSXV:PAIN) appoints NBA Champion Gary Payton II as Chief Athletic Ambassador for its sports medicine division.

Puff, puff, profit: Aurora Cannabis earns record revenue and adjusted EBITDA

Aurora Cannabis (TSX:ACB) earned record annual revenue and adjusted EBITDA in fiscal 2026, substantiating its shift into the medical market.

Apotex Health completes largest life sciences IPO in TSX history

Apotex Health (TSX:APTX) began trading today on the TSX, marking the largest life sciences IPO by total proceeds in the exchange's history.

Remote healthcare disruptor tops one million patient visits

Remote healthcare company UniDoc Health (CSE:UDOC) surpasses one million patient visits through its enterprise eHealth platform.

Healthcare micro-cap climbs after million-prescription milestone

TelyRx (TSX:TELY) recently filled its one millionth prescription, furthering its mission of expanding access to medications across the US.